Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Data Inf Manag ; 6(2): 100001, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1768034

ABSTRACT

The COVID-19 global pandemic has changed every facet of our lives overnight and has resulted in many challenges and opportunities. Utilizing the Lens of Vulnerability we investigate how disparities in technology adoption affect activities of daily living. In this paper, we analyze the existing literature and case studies regarding how the lifestyles of socially vulnerable populations have changed during the pandemic in terms of technology adoption. Socially vulnerable populations, such as racial and ethnic minorities, people with disabilities, older adults, children, and the socially isolated, are specifically addressed because they are groups of people who have been significantly and disproportionately affected by the pandemic. This paper emphasizes that despite seeing changes in and research on technology adoption across healthcare, employment, and education, the impact of COVID-19 in government and social services and activities of daily living is underdeveloped. The study concludes by offering practical and academic recommendations and future research directions. Lessons learned from the current pandemic and an understanding of the differential technology adoption for activities of daily living amid a disaster will help emergency managers, academics, and government officals prepare for and respond to future crises.

2.
J Med Internet Res ; 23(11): e31337, 2021 11 15.
Article in English | MEDLINE | ID: covidwho-1518441

ABSTRACT

BACKGROUND: The COVID-19 pandemic has highlighted the inability of health systems to leverage existing system infrastructure in order to rapidly develop and apply broad analytical tools that could inform state- and national-level policymaking, as well as patient care delivery in hospital settings. The COVID-19 pandemic has also led to highlighted systemic disparities in health outcomes and access to care based on race or ethnicity, gender, income-level, and urban-rural divide. Although the United States seems to be recovering from the COVID-19 pandemic owing to widespread vaccination efforts and increased public awareness, there is an urgent need to address the aforementioned challenges. OBJECTIVE: This study aims to inform the feasibility of leveraging broad, statewide datasets for population health-driven decision-making by developing robust analytical models that predict COVID-19-related health care resource utilization across patients served by Indiana's statewide Health Information Exchange. METHODS: We leveraged comprehensive datasets obtained from the Indiana Network for Patient Care to train decision forest-based models that can predict patient-level need of health care resource utilization. To assess these models for potential biases, we tested model performance against subpopulations stratified by age, race or ethnicity, gender, and residence (urban vs rural). RESULTS: For model development, we identified a cohort of 96,026 patients from across 957 zip codes in Indiana, United States. We trained the decision models that predicted health care resource utilization by using approximately 100 of the most impactful features from a total of 1172 features created. Each model and stratified subpopulation under test reported precision scores >70%, accuracy and area under the receiver operating curve scores >80%, and sensitivity scores approximately >90%. We noted statistically significant variations in model performance across stratified subpopulations identified by age, race or ethnicity, gender, and residence (urban vs rural). CONCLUSIONS: This study presents the possibility of developing decision models capable of predicting patient-level health care resource utilization across a broad, statewide region with considerable predictive performance. However, our models present statistically significant variations in performance across stratified subpopulations of interest. Further efforts are necessary to identify root causes of these biases and to rectify them.


Subject(s)
COVID-19 , Health Information Exchange , Humans , Pandemics , Patient Acceptance of Health Care , SARS-CoV-2 , United States
3.
J Am Board Fam Med ; 34(3): 498-508, 2021.
Article in English | MEDLINE | ID: covidwho-1259320

ABSTRACT

INTRODUCTION: One-third of the general public will not accept Coronavirus disease 2019 (COVID-19) vaccination but factors influencing vaccine acceptance among health care personnel (HCP) are not known. We investigated barriers and facilitators to vaccine acceptance within 3 months of regulatory approval (primary outcome) among adult employees and students at a tertiary-care, academic medical center. METHODS: We used a cross-sectional survey design with multivariable logistic regression. Covariates included age, gender, educational attainment, self-reported health status, concern about COVID-19, direct patient interaction, and prior influenza immunization. RESULTS: Of 18,250 eligible persons, 3,347 participated. Two in 5 (40.5%) HCP intend to delay (n = 1020; 30.6%) or forgo (n = 331; 9.9%) vaccination. Male sex (adjusted OR [aOR], 2.43; 95% confidence interval [CI], 2.00-2.95; P < .001), prior influenza vaccination (aOR, 2.35; 95% CI, 1.75-3.18; P < .001), increased concern about COVID-19 (aOR, 2.40; 95% CI, 2.07-2.79; P < .001), and postgraduate education (aOR, 1.41; 95% CI, 1.21-1.65; P < .001) - but not age, direct patient interaction, or self-reported overall health - were associated with vaccine acceptance in multivariable analysis. Barriers to vaccination included concerns about long-term side effects (n = 1197, 57.1%), safety (n = 1152, 55.0%), efficacy (n = 777, 37.1%), risk-to-benefit ratio (n = 650, 31.0%), and cost (n = 255, 12.2%).Subgroup analysis of Black respondents indicates greater hesitancy to accept vaccination (only 24.8% within 3 months; aOR 0.13; 95% CI, 0.08-0.21; P < .001). CONCLUSIONS: Many HCP intend to delay or refuse COVID-19 vaccination. Policymakers should impartially address concerns about safety, efficacy, side effects, risk-to-benefit ratio, and cost. Further research with minority subgroups is urgently needed.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Health Personnel , Vaccination/statistics & numerical data , Adult , Cross-Sectional Studies , Female , Humans , Male , Surveys and Questionnaires , Vaccination Refusal
SELECTION OF CITATIONS
SEARCH DETAIL